Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$1.94 -0.02 (-1.02%)
As of: Oct 20, 2026 · 3:58 PM EDT

Xtl Biopharmaceuticals (XTLB) Tax Rate (2012)

Updated

Xtl Biopharmaceuticals (XTLB) reported Tax Rate of 54.17% for the year ended Dec 31, 2024.

Analysis

Xtl Biopharmaceuticals (XTLB) Tax Rate (2012) Analysis & Trends

Dating back to the year ended Dec 31, 2009, Xtl Biopharmaceuticals' Tax Rate record includes 4 years.

  • The figure for the year ended Dec 31, 2024 ranks as the lowest annual Tax Rate since the year ended Dec 31, 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 23.27%
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 17.98%
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 15.47%
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 23.71%
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 10.40%
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 14.20%
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Xtl Biopharmaceuticals 18.55 Mn 15.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2012 4.95%
API Access

Xtl Biopharmaceuticals Tax Rate API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-rate&ticker=XTLB&period=max&api_key=YOUR_API_KEY